Bibliographic information

GuidelineGuidelines for the prevention, diagnosis, care and treatment for people with chronic hepatitis B infection.
Year of Publication2024
Issuing InstitutionWHO

Recommendation

Maintained

In settings or populations with an HBsAg seroprevalence of ≥0.4%, a single serological assay for detection of HBsAg is recommended, prior to further evaluation for HBV DNA and staging of liver disease. In settings or populations with a low HBsAg seroprevalence of <0.4%, confirmation of HBsAg positivity on the same immunoassay with a neutralization step or a second different rapid diagnostic test (RDT) assay for detection of HBsAg may be considered.

Recommended in favor

Conditional

Notes and Remarks

d Based on the results of predictive modelling of positive predictive values according to different thresholds of seroprevalence in populations to be tested and assay diagnostic performance. e A repeat HBsAg assay after six months is also a common approach used to confirm the chronicity of HBV infection.

Also Featured In

This recommendation also appears in the following guidelines:

Originally Developed
Guideline

WHO guidelines on hepatitis B and C testing.

Year2017
InstitutionWHO